Back

Inappropriate doses of non-vitamin K oral anticoagulants in clinical practice: prevalence and associated factors. A subanalysis of the FANTASIIA Registry

28 August 2017 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster session 4 - Stroke prevention Atrial fibrillation (AF) ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Martin Ruiz Ortiz

Reina Sofia University Hospital, Cordoba (Spain)

53 More presentations in this session

Presentation thumbnail
Doctor A. Tyminska (Warsaw, PL)
Abstract Slides
Presentation thumbnail
Doctor M. Gupta (Toronto, CA)
Abstract
Presentation thumbnail
Professor H. Bonnemeier (Luebeck, DE)
Abstract Slides
Presentation thumbnail
Ms D. Loikas (Stockholm, SE)
Abstract Slides
Presentation thumbnail
Doctor J. Franchino-Elder (Ridgefield, US)
Abstract

Access the full session

Session thumbnail
Poster session 4 - Stroke prevention

The Event

Event poster

ESC Congress 2017

28 August 2017 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Use of Non-vitamin K antagonist Oral Anticoagulants in a real-world setting: a community pharmacy-based study.
31 August 2019
thumbnail
Webinar
Antithrombotic treatment for dual pathway inhibition in cardiovascular disease patients
19 July 2023
thumbnail
Congress Presentation
Plasma levels of direct oral anticoagulants in non-valvular atrial fibrillation patients at the time of acute cardioembolic or bleeding events
28 August 2023
thumbnail
Congress Presentation
Reduced dose, but not reduced risk: rates of inappropriate apixaban dose reduction and stroke and bleeding incidence
27 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources